Choi YB - Search Results

1

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.

Park KS, Kim HK, Lee JH, Choi YB, Park SY, Yang SH, Kim SY, Hong KM. Park KS, et al. Among authors: choi yb. J Cancer Res Clin Oncol. 2010 Apr;136(4):493-502. doi: 10.1007/s00432-009-0681-6. Epub 2009 Sep 18. J Cancer Res Clin Oncol. 2010. PMID: 19763620

2

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.

Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR; Korean Thoracic Oncology Research Group (KTORG); Kim SY, Hong KM. Choi CM, et al. Among authors: choi yb. Mol Cancer. 2011 Sep 24;10:119. doi: 10.1186/1476-4598-10-119. Mol Cancer. 2011. PMID: 21943122 Free PMC article.

3

Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures.

Kim HS, Choi YB, Lee JH, Park SY, Kim HK, Koh JS, Yi SY, Kim KT, Hong KU, Park J, Bae CD, Hong KM. Kim HS, et al. Among authors: choi yb. J Cancer Res Clin Oncol. 2012 Jan;138(1):95-102. doi: 10.1007/s00432-011-1053-6. Epub 2011 Oct 22. J Cancer Res Clin Oncol. 2012. PMID: 22020800

4

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.

Ku BM, Kim SJ, Kim N, Hong D, Choi YB, Lee SH, Gong YD, Kim SY. Ku BM, et al. Among authors: choi yb. J Cancer Res Clin Oncol. 2014 May;140(5):757-67. doi: 10.1007/s00432-014-1623-5. Epub 2014 Mar 8. J Cancer Res Clin Oncol. 2014. PMID: 24610445

5

Immunohistochemical localization of LLC1 in human tissues and its limited expression in non-small cell lung cancer.

Chandra V, Choi YB, Hwang HL, Lee JH, Park SY, Kim HK, Poojan S, Koh JS, Kim HS, Hong KM. Chandra V, et al. Among authors: choi yb. Histol Histopathol. 2015 Sep;30(9):1111-20. doi: 10.14670/HH-11-608. Epub 2015 Mar 18. Histol Histopathol. 2015. PMID: 25786037

6

Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer.

Kim HS, Koh JS, Choi YB, Ro J, Kim HK, Kim MK, Nam BH, Kim KT, Chandra V, Seol HS, Noh WC, Kim EK, Park J, Bae CD, Hong KM. Kim HS, et al. Among authors: choi yb. PLoS One. 2014 Jun 2;9(6):e98160. doi: 10.1371/journal.pone.0098160. eCollection 2014. PLoS One. 2014. PMID: 24887265 Free PMC article.

7

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

Joo SY, Cho KA, Jung YJ, Kim HS, Park SY, Choi YB, Hong KM, Woo SY, Seoh JY, Cho SJ, Ryu KH. Joo SY, et al. Among authors: choi yb. Cytotherapy. 2010 May;12(3):361-70. doi: 10.3109/14653240903502712. Cytotherapy. 2010. PMID: 20078382

8

Cysteine carboxyl O-methylation of human placental 23 kDa protein.

Hong KM, Choi YB, Hong JH, Chang HS, Rhee KI, Park H, Paik MK. Hong KM, et al. Among authors: choi yb. Exp Mol Med. 1999 Mar 31;31(1):30-5. doi: 10.1038/emm.1999.5. Exp Mol Med. 1999. PMID: 10231020

9

Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis.

Hong KU, Choi YB, Lee JH, Kim HJ, Kwon HR, Seong YS, Kim HT, Park J, Bae CD, Hong KM. Hong KU, et al. Among authors: choi yb. Exp Mol Med. 2008 Aug 31;40(4):377-86. doi: 10.3858/emm.2008.40.4.377. Exp Mol Med. 2008. PMID: 18779650 Free PMC article.

10

Increased lysine N-methylation of a 23-kDa protein during hepatic regeneration.

Choi YB, Ko MH, Shin CH, Kim KS, Hong KM, Paik MK, Park DE. Choi YB, et al. Exp Mol Med. 2005 Jun 30;37(3):155-60. doi: 10.1038/emm.2005.21. Exp Mol Med. 2005. PMID: 16000868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters